107 related articles for article (PubMed ID: 27218431)
1. Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics.
Davidson T; Komissar O; Goshen E; Shalmon B; Chikman B; Ben-Nun A; Ben-Haim S
Nucl Med Commun; 2016 Sep; 37(9):969-74. PubMed ID: 27218431
[TBL] [Abstract][Full Text] [Related]
2. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
Basu S; Houseni M; Alavi A
Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
[TBL] [Abstract][Full Text] [Related]
3. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
[TBL] [Abstract][Full Text] [Related]
4. Predictors of pathologic outcome of focal FDG uptake in the parotid gland identified on whole-body FDG PET imaging.
Mabray MC; Behr SC; Naeger DM; Flavell RR; Glastonbury CM
Clin Imaging; 2015; 39(6):1073-9. PubMed ID: 26324219
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of parotid gland incidentalomas on (18)F-FDG PET/CT.
Makis W; Ciarallo A; Gotra A
Clin Imaging; 2015; 39(4):667-71. PubMed ID: 25888252
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis.
Treglia G; Bertagna F; Sadeghi R; Muoio B; Giovanella L
Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3617-26. PubMed ID: 25262193
[TBL] [Abstract][Full Text] [Related]
7. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Significance of Incidental Parotid Uptake in a PET/CT Study: A Diagnostic Algorithm.
Üstün F; Taştekin E; Taş A; Altun GD
Curr Med Imaging Rev; 2019; 15(3):326-333. PubMed ID: 31989884
[TBL] [Abstract][Full Text] [Related]
9. Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters.
Hadiprodjo D; Ryan T; Truong MT; Mercier G; Subramaniam RM
AJR Am J Roentgenol; 2012 Feb; 198(2):W185-90. PubMed ID: 22268210
[TBL] [Abstract][Full Text] [Related]
10. Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
Kendi AT; Magliocca KR; Corey A; Galt JR; Switchenko J; Wadsworth JT; El-Deiry MW; Schuster DM; Saba NF; Hudgins PA
AJR Am J Roentgenol; 2016 Sep; 207(3):635-40. PubMed ID: 27276388
[TBL] [Abstract][Full Text] [Related]
11. Parotid incidentalomas: a systematic review.
Thompson C; Nolli T; Bannister M
J Laryngol Otol; 2021 Sep; 135(9):765-769. PubMed ID: 34308809
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they?
Hassan A; Riaz S; Zafar W
Nucl Med Commun; 2016 Oct; 37(10):1069-73. PubMed ID: 27571130
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
Shmidt E; Nehra V; Lowe V; Oxentenko AS
BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
[TBL] [Abstract][Full Text] [Related]
14. Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
Vatankulu B; Işik G; Kocael P; Kuyumcu S; Ilvan Ş; Sağer S; Halaç M; Türkmen C; Sönmezoğlu K
Nucl Med Commun; 2016 Dec; 37(12):1273-1281. PubMed ID: 27472037
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
Kim BS; Kim SJ; Pak K
Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses.
Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH
Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540
[TBL] [Abstract][Full Text] [Related]
18. Incidental diagnosis of tumor thrombosis on FDG PET/CT imaging.
Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):287-94. PubMed ID: 26025479
[TBL] [Abstract][Full Text] [Related]
19.
Baha A; Yildirim F; Kokturk N; Akdemir UO; Demircan S; Turktas H
Clin Respir J; 2016 Nov; 10(6):740-745. PubMed ID: 25689088
[TBL] [Abstract][Full Text] [Related]
20. Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland.
Basu S; Mahne A; Iruvuri S; Alavi A
Clin Lymphoma Myeloma; 2007 Jan; 7(4):309-14. PubMed ID: 17324340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]